GM-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense

Annual Review of Physiology

Volumn 64, Issue , 2002, Pages 775-802

  Trapnell, Bruce C ^a   Whitsett, Jeffrey A ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Differentiation; GM CSF receptor; PU.1; Signaling; Transcriptional control

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; GROWTH FACTOR RECEPTOR; LUNG SURFACTANT; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR PU 1;

CELL ADHESION; CELL DIFFERENTIATION; GENE MUTATION; HOMEOSTASIS; HOST RESISTANCE; HUMAN; IMMUNOREGULATION; LUNG ALVEOLUS MACROPHAGE; LUNG ALVEOLUS PROTEINOSIS; NONHUMAN; ONTOGENY; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HOMEOSTASIS; LUNG; MACROPHAGES, ALVEOLAR; PULMONARY SURFACTANTS; SIGNAL TRANSDUCTION;

EID: 0036201268     PISSN: 00664278     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.physiol.64.090601.113847     Document Type: Review

References (135)

1. Purification and properties of colony-stimulating factor from mouse lung-conditioned medium
2. Molecular cloning of cDNA encoding a murine haematopoietic growth regulator, granulocyte-macrophage colony stimulating factor
3. Granulocyte-macrophage colony stimulating factor
4. Granulocyte-macrophage colony-stimulating factor and the immune system
5. Clonal analysis of proliferation and differentiation of paired daughter cells: Action of granulocyte-macrophage colony-stimulating factor on granulocyte-macrophage precursors
6. Direct stimulation by purified GM-CSF of the proliferation of multipotential and erythroid precursor cells
7. Detection of a new type of mouse eosinophil colony by Luxol-fast-blue staining
8. Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow
9. Cellular hematopoiesis in the twentieth century
10. Effects of granulocyte-macrophage colony-stimulating factor and colony-stimulating factor-1 on the proliferation and differentiation of murine alveolar macrophages
11. Selective expansion of alveolar macrophages in vivo by adenovims-mediated transfer of the murine granulocyte-macrophage colony-stimulating factor cDNA
12. M-CSF and GM-CSF promote alveolar macrophage differentiation into multinucleated giant cells with distinct phenotypes
13. Granulocyte-macrophage colony-stimulating factor promotes the proliferation of human alveolar macrophages in vitro
14. GM-CSF enhances lung growth and causes alveolar type II epithelial cell hyperplasia in transgenic mice
15. Assignment of the GM-CSF, CSF-1, and FMS genes to human chromosome 5 provides evidence for linkage of a family of genes regulating hematopoiesis and for their involvement in the deletion (5q) in myeloid disorders
16. Close genetic and physical linkage between the murine haemopoietic growth factor genes GM-CSF and multi-CSF (IL3)
17. Fine-structure mapping of the murine IL-3 and GM-CSF genes by pulsed-field gel electrophoresis and molecular cloning
18. Structure of the chromosomal gene for granulocyte-macrophage colony stimulating factor: Comparison of the mouse and human genes
19. A model for the interaction of the GM-CSF, IL-3 and IL-5 receptors with their ligands
20. Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor
21. Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): Reconstitution of a high-affinity GM-CSF receptor
22. JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region
23. The cytoplasmic domain of granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor alpha subunit is essential for both GM-CSF-mediated growth and differentiation
24. Tyrosine phosphorylation of receptor beta subunits and common substrates in response to interleukin-3 and granulocyte-macrophage colony-stimulating factor
25. Critical cytoplasmic domains of the common beta subunit of the human GM-CSF, IL-3 and IL-5 receptors for growth signal transduction and tyrosine phosphorylation
26. Roles of JAK kinases in human GM-CSF receptor signal transduction
27. A model for assembly and activation of the GM-CSF, IL-3 and IL-5 receptors: Insights from activated mutants of the common beta subunit
28. Abnormal Stat activation, hematopoietic homeostasis, and innate immunity in c-fes-/- mice
29. The SH2 domain-containing protein tyrosine phosphatase SHP-1 is induced by granulocyte colony-stimulating factor (G-CSF) and modulates signaling from the G-CSF receptor
30. The functional basis of granulocyte-macrophage colony stimulating factor, interleukin-3 and interleukin-5 receptor activation, basic and clinical implications
31. Function and regulation of expression of pulmonary surfactant-associated proteins
32. Surfactant phospholipids: Synthesis and storage
33. Clearance and recycling of pulmonary surfactant
34. Specific binding of surfactant apoprotein SP-A to rat alveolar macrophages
35. The interaction of a lung surfactant protein (SP-A) with macrophages is mannose dependent
36. Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophage
37. Pulmonary-specific expression of SP-D corrects pulmonary lipid accumulation in SP-D gene-targeted mice
38. Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D
39. Surfactant metabolism
40. Recycling of surfactant in black and beige mice: Pool sizes and kinetics
41. Regulation of lung surfactant secretion
42. Pulmonary alveolar proteinosis
43. Biochemical characterization of pulmonary washings of patients with alveolar proteinosis, interstitial pneumonitis and alveolar cell carcinoma
44. Accumulation of surfactant protein D in human pulmonary alveolar proteinosis
45. Pulmonary alveolar proteinosis
46. Alveolar proteinosis and the overfed macrophage
47. Defective lung macrophages in pulmonary alveolar proteinosis
48. Pulmonary alveolar proteinosis: Its association with hematologic malignancy and lymphoma
49. Pulmonary alveolar proteinosis complicating chronic myelogenous leukemia
50. Pulmonary complications of leukemia
51. Pulmonary alveolar proteinosis in association with Fanconi's anemia and psoriasis. A possible common pathogenetic mechanism
52. Pulmonary alveolar proteinosis in a painter with elevated pulmonary concentrations of titanium
53. Alveolar proteinosis and phospholipidoses of the lungs
54. Induction of intra- and extra-cellular phospholipids in the lungs of rats exposed to silica
55. Secondary pulmonary alveolar proteinosis occurring in two patients with acquired immune deficiency syndrome
56. Pulmonary alveolar proteinosis in SCID mice
57. Changes in the composition of lung lipids and the "turnover" of dipalmitoyl lecithin in experimental alveolar lipoproteinosis induced by inhaled quartz
58. Pulmonary alveolar phospholipoproteinosis induced by Orasol Navy Blue dust
59. Granulocyte/ macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology
60. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis
61. GM-CSF-deficient mice are susceptible to pulmonary group B streptococcal infection
62. Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice
63. Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablation
64. Molecular physiology of granulocyte-macrophage colony-stimulating factor
65. Secretion of cytokines by rat alveolar epithelial cells: Possible regulatory role for SP-A
66. Production of granulocyte-macrophage colony-stimulating factor by cultured human tracheal epithelial cells
67. Rat tracheal epithelial cells produce granulocyte/macrophage colony-stimulating factor
68. Antiinflammatory steroids inhibit granulocyte/ macrophage colony-stimulating factor production by human lung tissue
69. Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice
70. Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice
71. Adenovirus-mediated granulocyte-macrophage colony-stimulating factor improves lung pathology of pulmonary alveolar proteinosis in granulocyte-macrophage colony-stimulating factor-deficient mice
72. Surfactant metabolic consequences of overexpression of GM-CSF in the epithelium of GM-CSF-deficient mice
73. The pulmonary alveolar proteinosis in granulocyte macrophage colony-stimulating factor/interleukins 3/5 beta c receptor-deficient mice is reversed by bone marrow transplantation
74. GM-CSF regulates surfacant Protein-A and lipid catabolism by alveolar macrohpages
75. Surfactant metabolism in SP-D gene-targeted mice
76. SP-D and GM-CSF regulate surfactant homeostasis via distinct mechanisms
77. Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normal
78. Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5
79. Evidence that granulocyte macrophage colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers
80. Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression
81. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor
82. Serological diagnosis of idiopathic pulmonary alveolar proteinosis
83. Lungs of patients with idiopathic pulmonary alveolar proteinosis express a factor which neutralizes granulocyte-macrophage colony stimulating factor
84. Efficacy of granulocyte-macrophage colony-stimulating factor in acquired alveolar proteinosis
85. Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis
86. The alveolar macrophage
87. Pulmonary macrophages
88. Innate immunity
89. Cell number and cell characteristics of the normal human lung
90. Mechanisms of phagocytosis in macrophages
91. The origin and kinetics of mononuclear phagocytes
92. Direct evidence for a bone marrow origin of the alveolar macrophage in man
93. Differentiation of the mononuclear phagocyte system during mouse embryogenesis: The role of transcription factor PU.1
94. Alveolar macrophage replication. One mechanism for the expansion of the mononuclear phagocyte population in the chronically inflamed lung
95. Mature monocytic cells enter tissues and engraft
96. Production and migration of monocytes and macrophages
97. The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80. Relationship between macrophages, Langerhans cells, reticular cells, and dendritic cells in lymphoid and hematopoietic organs
98. Specificity of action of colony-stimulating factors in the differentiation of granulocytes and macrophages
99. The human hematopoietic colony-stimulating factors
100. Preclinical studies on synergistic effects of IL-1, IL-3, G-CSF and GM-CSF in cynomolgus monkeys
101. Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 functions
102. Biosynthetic human GM-CSF modulates the number and affinity of neutrophil f-Met-Leu-Phe receptors
103. Human recombinant granulocyte-macrophage colony-stimulating factor increases cell-to-cell adhesion and surface expression of adhesion-promoting surface glycoproteins on mature granulocytes
104. GM-CSF induces human neutrophil IgA-mediated phagocytosis by an IgA Fc receptor activation mechanism
105. Cytokine enhancement of complement-dependent phagocytosis by macrophages: Synergy of tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans
106. Macrophage colony-stimulating factor (M-CSF) enhances the capacity of murine macrophages to secrete oxygen reduction products
107. Granulocyte-macrophage colony-stimulating factor enhances selective effector functions of tissue-derived macrophages
108. Granulocyte-macrophage colony-stimulating factor enhances phagocytosis of bacteria by human neutrophils
109. Granulocyte-macrophage colony-stimulating factor: Pleiotropic cytokine with potential clinical usefulness
110. Recombinant human granulocyte/macrophage colony-stimulating factor activates intracellular killing of Leishmania donovani by human monocyte-derived macrophages
111. Granulocyte macrophage colony-stimulating factor improves survival in two models of gut-derived sepsis by improving gut barrier function and modulating bacterial clearance
112. Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells
113. Role of granulocyte/macrophage colony-stimulating factor in the regulation of murine alveolar macrophage proliferation and differentiation
114. Serial analysis of gene expression in human monocytes and macrophages
115. Pulmonary alveolar proteinosis
116. Pulmonary alveolar proteinosis: Abnormal in vitro function of alveolar macrophages
117. Pulmonary alveolar proteinosis. Further evaluation of abnormal alveolar macrophages
118. Improvement in alveolar macrophage function after therapeutic lung lavage in pulmonary alveolar proteinosis
119. Alveolar proteinosis: Restoration of the function of the alveolar macrophages after therapeutic lavage
120. Alveolar macrophage-mediated adenovirus uptake and clearance from the lung is modulated by granulocyte-macrophage colony stimulating factor
121. GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1
122. GM-CSF regulates innate immunity in the lung by coordinate, marked stimulation of phagocytosis, pathogen killing and toll receptor signaling in alveolar macrophages through the transcription factor PU.1
123. Arrest of alveolar macrophage differentiation, in vivo, in GM-CSF-deficient mice is associated with altered expression of transcription factors PU.1 and ICSBP
124. Transcription factors, normal myeloid development, and leukemia
125. The key role of PU.1/SPI-1 in B cells, myeloid cells and macrophages
126. Transcription factors that regulate monocyte/macrophage differentiation
127. The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene
128. Requirement of transcription factor PU. 1 in the development of multiple hematopoietic lineages
129. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
130. PU.1 is not essential for early myeloid gene expression but is required for terminal myeloid differentiation
131. The transcription factor PU.1 is involved in macrophage proliferation
132. PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors
133. PU.1 (Spi-1) autoregulates its expression in myeloid cells
134. Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage
135. Mice lacking both macrophage- and granulocyte-macrophage-colony stimulating factor have macrphages and coexistent osteopetrosis and severe lung disease